TABLE 1.
Association of LGMN expression with clinicopathological variables in pancreatic ductal adenocarcinoma.
| Clinicopathological characteristic | n (%) | LGMN staining (n; %) | p-value | |
|---|---|---|---|---|
| Low | High | |||
| Age (year) | 0.137 | |||
| <60 | 86 (48.86) | 42 (48.84) | 44 (51.16) | |
| ≥60 | 90 (51.14) | 54 (60.00) | 36 (40.00) | |
| Sex | 0.224 | |||
| Male | 108 (61.36) | 55 (50.93) | 53 (49.07) | |
| Female | 68 (38.64) | 41 (60.29) | 27 (39.71) | |
| Clinical stages | *0.004 | |||
| I/II | 138 (78.41) | 83 (60.14) | 55 (39.86) | |
| III/IV | 38 (21.59) | 13 (34.21) | 25 (65.79) | |
| Tumor location | 0.198 | |||
| Head | 112 (63.64) | 57 (50.89) | 55 (49.11) | |
| Body/tail | 64 (36.36) | 39 (60.93) | 25 (39.07) | |
| Tumor size | 0.160 | |||
| ≤4 cm | 58 (32.95) | 36 (62.07) | 22 (37.93) | |
| >4 cm | 118 (67.05) | 60 (50.85) | 58 (49.15) | |
| Differentiation | *0.012 | |||
| Weak to moderately | 110 (62.50) | 68 (61.82) | 42 (38.18) | |
| Poorly | 66 (37.50) | 28 (42.42) | 38 (57.58) | |
| N infiltration | 0.060 | |||
| Positive | 165 (93.75) | 87 (52.73) | 78 (47.27) | |
| Negative | 11 (6.25) | 9 (81.82) | 2 (18.18) | |
| Lymphnode infiltration | *0.020 | |||
| Positive | 128 (72.73) | 63 (49.22) | 65 (50.78) | |
| Negative | 48 (27.27) | 33 (68.75) | 15 (31.25) | |